Related Experiment Video
Updated: Mar 24, 2026
Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
[Screening differential expression of docetaxel-resistance related genes of human lung adenocarcinoma cell line
Hai Sun1, Jian Geng, Longbang Chen
1Oncology Department, Nanjing General Hospital of Nanjing Command, Nanjing, Jiangsu 210002, P.R.China.
Background:
Docetaxel is one of effective chemotherapeutics in the last few years, however, it is interfered by drug resistance in its further application. The aim of this study is to screen differentially expressed genes of docetaxel resistant cell line SPC-A1/Docetaxel and its parent cell line SPC-A1 with gene chip technique.
Methods:
The cDNA retro-transcribed from equal quantity mRNA derived from SPC-A1/Docetaxel and SPC-A1 cell lines. The mixed probes were hybridized with Affymetrix GeneChip HG-U133A2.0. The acquired image was analyzed by Affymetrix GeneChip Operating Software Version 1.0. Then, part of these results were verified by RT-PCR.
Results:
A total of 934 differentially expressed genes were screened out, in which up-and down-regulated genes were 428 and 506 respectively. These genes involved in ABC transporter, apoptosis regulator, tubulin, signal transducer, enzyme and so on.
Conclusions:
These differentially expressed genes may be related to the mechanisms of docetaxel resistance in SPC-A1/Docetaxel cell line.
Insights
This study identified 934 differentially expressed genes in docetaxel-resistant lung cancer cells (SPC-A1/Docetaxel) compared to parent cells. These genes, including ABC transporters and apoptosis regulators, offer insights into docetaxel resistance mechanisms.
Area of Science:
- Molecular biology
- Genomics
- Cancer research
Context:
- Docetaxel is a key chemotherapy drug, but its efficacy is limited by acquired drug resistance.
- Understanding the genetic basis of docetaxel resistance is crucial for improving treatment outcomes.
Purpose:
- To identify differentially expressed genes between a docetaxel-resistant lung cancer cell line (SPC-A1/Docetaxel) and its parental cell line (SPC-A1).
- To investigate the molecular mechanisms underlying docetaxel resistance using gene chip technology.
Summary:
- Gene chip analysis revealed 934 differentially expressed genes (428 upregulated, 506 downregulated) between SPC-A1/Docetaxel and SPC-A1 cells.
- Key affected pathways include ABC transporters, apoptosis regulation, tubulin dynamics, and signal transduction.
- Reverse transcription-polymerase chain reaction (RT-PCR) validated a subset of these gene expression changes.
Impact:
- The identified genes provide potential targets for overcoming docetaxel resistance in lung cancer.
- This research contributes to a deeper understanding of the complex molecular mechanisms of chemotherapy resistance.
- Findings may inform the development of novel therapeutic strategies to enhance docetaxel efficacy.
